- Conditions
- Type 2 Diabetes
- Interventions
- eButton, Continuous Glucose Monitoring (CGM)
- Device
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 38
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Obesity (Disorder)
- Interventions
- Abbot Freestyle Libre CGM
- Device
- Lead sponsor
- Pennington Biomedical Research Center
- Other
- Eligibility
- 20 Years to 60 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Baton Rouge, Louisiana
- Conditions
- Type 1 Diabetes, Type 2 Diabetes
- Interventions
- Freestyle Libre 3
- Device
- Lead sponsor
- University of the Pacific
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Stockton, California
- Conditions
- Type 2 Diabetes
- Interventions
- FreeStyle Libre 2/Libre 3+ Continuous Glucose Monitor
- Device
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- type1diabetes
- Interventions
- Libre 2, Device for SMBG and Libre Pro
- Device
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- 4 Years to 26 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Cystic Fibrosis, Cystic Fibrosis-related Diabetes, Cystic Fibrosis Liver Disease, Pancreatic Steatosis, Hepatic Steatosis
- Interventions
- Frequently Sampled Oral Glucose Tolerance Test and CGM, MRI Pancreas and Liver
- Device · Radiation
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Other
- Eligibility
- 6 Years to 40 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Ketosis Prone Diabetes
- Interventions
- Continuous Glucose Monitoring, Insulin
- Device · Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia
- Conditions
- Diabete Mellitus
- Interventions
- FreeStyle Libre
- Device
- Lead sponsor
- Abbott Diabetes Care
- Industry
- Eligibility
- 2 Years and older
- Enrollment
- 332 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 5
- States / cities
- Santa Barbara, California • Atlanta, Georgia • Idaho Falls, Idaho + 2 more
- Conditions
- Metastatic Breast Cancer
- Interventions
- Alpelisib, FreeStyle Libre 2 Continuous Glucose Monitor
- Drug · Device
- Lead sponsor
- HealthPartners Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 8 participants
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Saint Louis Park, Minnesota
- Conditions
- Diabetes Mellitus
- Interventions
- To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists
- Device
- Lead sponsor
- Abbott Diabetes Care
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 2
- States / cities
- Jacksonville, Florida • Miami Gardens, Florida
- Conditions
- Stress, Blood Sugar; High, Cholesterol, Elevated, Diet Habit
- Interventions
- 7-Day Continuous Glucose Monitoring with Abbott Freestyle Libre 2
- Device
- Lead sponsor
- Karol E. Watson, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Type 2 Diabetes
- Interventions
- FreeStyle Libre Continuous Glucose Monitor System
- Device
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 8 Years to 20 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Type 2 Diabetes
- Interventions
- Continuous Glucose Monitoring (CGM)
- Device
- Lead sponsor
- HealthPartners Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 178 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Gastroparesis With Diabetes Mellitus
- Interventions
- FreeStyle Libre 3 continuous glucose monitoring sensor, Nutritional drink
- Device · Other
- Lead sponsor
- Samita Garg
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Type 2 Diabetes
- Interventions
- The DECIDE Self-Management Program, Continuous Glucose Monitoring (CGM)
- Behavioral
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Manhasset, New York
- Conditions
- PreDiabetes, Obesity, Insulin Resistance
- Interventions
- Abbott Freestyle Libre 2, Standard physical activity and nutritional counseling for prediabetes management
- Device · Other
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 11 Years and older
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Diabetes Mellitus, Type 2, Hypoglycemia
- Interventions
- FreeStyle Libre 2 CGM, FreeStyle Libre Pro blinded CGM, FreeStyle Precision Neo blood glucose meter
- Device
- Lead sponsor
- Palo Alto Medical Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 2
- States / cities
- Palo Alto, California • Atlanta, Georgia
- Conditions
- Diabetes, Type 2 Diabetes
- Interventions
- FreeStyle Libre
- Device
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Manhasset, New York
- Conditions
- Heart Failure, Diabetes Mellitus
- Interventions
- Libre 2 rt-CGM, POC BG + Blinded CGM
- Device · Diagnostic Test
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Type 2 Diabetes, Mild Cognitive Impairment
- Interventions
- Continuous Glucose Monitor (CGM)
- Device
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 65 Years to 100 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Type 2 Diabetes
- Interventions
- Online Diabetes Self-Management Education and Support (DSMES) Program, Standard of Care
- Behavioral
- Lead sponsor
- Omada Health, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- San Mateo, California
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- FreeStyle Libre 2 Flash Glucose Monitoring System
- Device
- Lead sponsor
- Abbott Diabetes Care
- Industry
- Eligibility
- 30 Years to 70 Years
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Renton, Washington
- Conditions
- Diabete Mellitus
- Interventions
- Freestyle Libre
- Device
- Lead sponsor
- Methodist Medical Center of Illinois
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 1
- States / cities
- Peoria, Illinois
- Conditions
- Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Prediabetic State
- Interventions
- Diazoxide oral suspension, 1 mg per kg per dose, Diazoxide oral suspension, 2 mg per kg per dose, Placebo, FreeStyle Libre Pro, Deuterated water (2H2O/D2O)
- Drug · Device
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- New York, New York